Molecular Advances in Inflammatory Bowel Disease
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 1 June 2024 | Viewed by 202
Special Issue Editors
Interests: inflammatory bowel disease; ulcerative colitis; gastrointestinal disorders
Special Issue Information
Dear Colleagues,
Inflammatory bowel diseases (IBDs) are chronic digestive diseases that affect the gastrointestinal system, primarily ulcerative colitis and Crohn's disease. The therapeutic management of IBDs lies in medical therapy (traditional and biological) and, when required, surgical treatment. This Special Issue aims to collect recent research in the field of molecular advances in IBD in a range of possibilities, from the rediscovery and/or implementation of new diagnostic/prognostic molecular methods (including IBD gastrointestinal endoscopy) to new evidence related to traditional and biological therapy (including small molecules and drug monitoring). Hearings will also be given to papers about patient-reported outcomes connected to all aspects of quality of life for patients with IBD if related to molecular mediators.
Dr. Antonietta Gerarda Gravina
Dr. Raffaele Pellegrino
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- Crohn’s disease
- ulcerative colitis
- biologics
- quality of life
- diagnostic markers
- prognostic markers
- drug monitoring
- antibodies
